Dr. Xinghuai Sun 孙兴怀
Ophthalmology
Eye & ENT Hospital of Fudan University, Shanghai
Appointment requests We can help you request an appointment with Dr. Xinghuai Sun. Profile compiled from public sources.
Ask us to arrange itCurrent positions
- Professor and Chief Physician (glaucoma), Eye & ENT Hospital of Fudan University
Checked against a public report (检索 2026-11-15). Positions change; the hospital's website is the final word.
Clinical focus: Surgical treatment for refractory glaucoma, including implantation of glaucoma drainage devices. Combined surgery for glaucoma and cataracts. Comprehensive management of primary angle-closure glaucoma, optic nerve diseases, and complex glaucoma cases.
Conditions and procedures: Refractory glaucoma, Primary angle-closure glaucoma, Glaucoma with cataracts, Optic nerve diseases
Compiled from public information; not confirmed with the hospital or the doctor.
Name order: in Chinese the family name comes first (Sun Xinghuai). Papers usually list the name as Xinghuai Sun.
Selected publications
67 first- or senior-author papers on PubMed where the author's own affiliation is this hospital (67 since 2016), counted among the 200 most recent matching papers. Most recent:
- Front Immunol, 2026 (senior author): Clinical value evaluation of MEG3/miR-144-3p as a biomarker for the early diagnosis of glaucoma. PubMed 42978717
- Ocul Surf, 2026 (senior author): Lifitegrast ophthalmic solution 5.0% (KH732) for dry eye disease: A randomized, multicenter, double-masked, vehicle-controlled phase 3 trial. PubMed 42069335
- Sci Rep, 2026 (senior author): Plasma-aqueous dual-fluid NEAT1/miR-93-5p axis may be involved in retinal ganglion cell degeneration in glaucoma: mechanistic dissection and diagnostic model construction. PubMed 42120436
- Life (Basel), 2026 (senior author): Complement, Inflammasome, and Microglial Crosstalk in Glaucoma: From Neurodegeneration to Immune-Based Precision Therapy. PubMed 41900887
- Int J Surg, 2026 (senior author): Phosphatidylcholine modulates trabecular meshwork resilience to glaucomatous injury via regulation of TGFBR3 signaling. PubMed 41664644
- Ophthalmic Res, 2026 (senior author): Stem Cell-Based Interventions for Retinal Ganglion Cell Protection and Regeneration in Glaucoma: A Review of Current Evidence and Future Directions. PubMed 42228681
- Sci Rep, 2025 (senior author): Targeted LC-MS profiling reveals dysregulated glycolytic flux and TCA cycle stalling in POAG plasma. PubMed 41034373
- Front Cell Dev Biol, 2025 (senior author): Metabolic alterations within the primary visual cortex in blind patients with end-stage glaucoma: a proton magnetic resonance spectroscopy study. PubMed 40655950
Each paper was checked automatically: the author listed with this name must give this hospital as their affiliation. See the full PubMed search.
The doctor has not reviewed this profile or any other content on this website. How we build this directory.
Want to see Dr. Xinghuai Sun?
Tell us about the problem and send any records. We can help you request an appointment with Dr. Xinghuai Sun, or with another specialist in this field if that suits your case better.
Ask us to arrange it